Showing 1 - 10 of 66
Case review 2019-11-14
In Bailey & Ors v GlaxoSmithKline “The Seroxat Group Litigation” [08.11.19] the Court of Appeal decided that it was impermissible for the claimants to expand the scope of their pleaded case at trial, which was previously determined at both the case management stage and during the pre-trial review.
Case review 2019-10-30
Supreme Court unanimously concludes that insurers were not liable to pay the uninsured claimants’ costs
Today, the Supreme Court has sensibly overturned the decisions of the lower courts in Travelers in concluding that Travelers’ conduct did not cross the line into ‘unjustified intermeddling’ (per TGA Chapman Limited v Christopher ) in litigation to which it was not a party.
With the current Article 50 extension deadline of 31 October 2019 looming against a complex and uncertain political backdrop, and talks between the UK and EU continuing without any clear sign of a definitive outcome, the possibility of a no-deal Brexit remains at an all-time high.
Boris Johnson’s first Queen’s Speech delivered on Monday 14 October 2019 - dominated by Brexit-related legislation - included the Medicines and Medical Devices Bill (the Bill).
Following today's Queen's Speech, we have officially responded to some key domestic legislation relating Air Traffic Management and Unmanned Aircraft Bill, and the Medicines and Medical Devices Bill.
In a week that is likely to be dominated by ongoing Brexit negotiations and timelines, we have today been provided with this Government’s priorities and legislative programme in the Queen’s Speech which took place this morning.
The way in which people and goods travel is changing rapidly. The shift towards transport in which machines are increasingly taking control from humans raises fundamental considerations around public safety, ethical dilemmas and where liability rests when accidents occur. It also means a major shift in the amount of data that is collected by vehicles, and how that data is stored and used.
Widespread adoption of autonomous vehicles will herald dramatic changes for the motor insurance market according to our recently published report.
Awareness around the use of medical cannabis has increased, as has legal availability across many jurisdictions. Countries in Europe and North America have responded to the demand.
British people are the least supportive nation in their attitude towards driverless cars, or indeed any form of autonomous vehicle (AV), according to a study across six territories (United Kingdom, United States, Australia, China, Singapore and Hong Kong).